These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24778016)

  • 1. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer.
    Alegre MM; Weyant MJ; Bennett DT; Yu JA; Ramsden MK; Elnaggar A; Robison RA; O'Neill KL
    Anticancer Res; 2014 May; 34(5):2145-51. PubMed ID: 24778016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
    Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
    PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
    Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
    Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays.
    Kumar JK; Holmgren S; Levedahl KH; Höglund M; Venge P; Eriksson S
    Biotechniques; 2020 Jun; 68(6):334-341. PubMed ID: 32336110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer.
    Li HX; Lei DS; Wang XQ; Skog S; He Q
    Oncol Rep; 2005 Jan; 13(1):145-9. PubMed ID: 15583816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
    Jagarlamudi KK; L S; M Z; J O; P V; S E
    PLoS One; 2022; 17(10):e0275444. PubMed ID: 36201558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
    Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
    Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
    Jagarlamudi KK; Shaw M
    Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report.
    Nisman B; Nechushtan H; Biran H; Gantz-Sorotsky H; Peled N; Gronowitz S; Peretz T
    J Thorac Oncol; 2014 Oct; 9(10):1568-72. PubMed ID: 25521401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-Based Sandwich Assay for Measurement of Thymidine Kinase 1 in Serum of Cancerous Patients.
    Nazari M; Gargari SLM; Sahebghadam Lotfi A; Rassaee MJ; Taheri RA
    Biochemistry; 2019 May; 58(18):2373-2383. PubMed ID: 30900869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
    Jagarlamudi KK; Hansson LO; Eriksson S
    BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.
    Wu BJ; Li WP; Qian C; Ding W; Zhou ZW; Jiang H
    Tumour Biol; 2013 Apr; 34(2):643-8. PubMed ID: 23179401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
    He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
    Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thymidine kinase 1 activity in breast cancer.
    Nisman B; Allweis T; Kaduri L; Maly B; Gronowitz S; Hamburger T; Peretz T
    Cancer Biomark; 2010; 7(2):65-72. PubMed ID: 21178264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma.
    He E; Xu XH; Guan H; Chen Y; Chen ZH; Pan ZL; Tang LL; Hu GZ; Li Y; Zhang M; Zhou J; Eriksson S; Fornander T; Skog S
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):352-8. PubMed ID: 20544519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.
    Carlsson L; Larsson A; Lindman H
    Ups J Med Sci; 2009; 114(2):116-20. PubMed ID: 19396699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer.
    Xi QP; Pu DH; Lu WN
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4536-4541. PubMed ID: 29131263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and Liver.
    Nisman B; Appelbaum L; Yutkin V; Nechushtan H; Hubert A; Uziely B; Pode D; Peretz T
    Anticancer Res; 2016 Apr; 36(4):1791-7. PubMed ID: 27069161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
    Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
    BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.